Omega Fund Management, LLC Long-Term Concentrated

CIK: 0001637359 · Show all filings

Period: Q4 2023 (← Previous) (Next →)

Filing Date: Feb 14, 2024

Total Value ($000): $123,437 (100.0% shares, 0.0% debt)

Holdings (14)

LXEO Lexeo Therapeutics 23.5%

Value ($000) $28,955 Shares 2,157,623 Est. Cost $12.42 Unrealized 0.0%

REPL Replimune Group 20.5%

Value ($000) $25,301 Shares 3,001,319 Est. Cost $17.40 Unrealized -33.4%

NUVB Nuvation Bio 18.4%

Value ($000) $22,759 Shares 15,072,340 Est. Cost $11.18 Unrealized -88.5%

ENGN enGene Holdings Inc. 8.5%

Value ($000) $10,441 Shares 1,131,175 Est. Cost $10.40 Unrealized 0.0%

— Morphic Holding 7.2%

Value ($000) $8,948 Shares 309,846 Est. Cost $19.82 Unrealized —

— Spruce Biosciences 5.1%

Value ($000) $6,332 Shares 2,161,022 Est. Cost $24.31 Unrealized —

— Kronos Bio 3.9%

Value ($000) $4,773 Shares 3,818,283 Est. Cost $29.87 Unrealized —

— Ikena Oncology 3.6%

Value ($000) $4,431 Shares 2,249,123 Est. Cost $28.25 Unrealized —

SANA Sana Biotechnology, Inc. 2.8%

Value ($000) $3,443 Shares 843,750 Est. Cost $32.56 Unrealized -88.7%

— Theseus Pharmaceuticals 2.3%

Value ($000) $2,881 Shares 711,479 Est. Cost $12.68 Unrealized —

IMUX Immunic Inc 2.2%

Value ($000) $2,682 Shares 1,788,160 Est. Cost $13.89 Unrealized -91.2%

SYRS Syros Pharmaceuticals 1.6%

Value ($000) $1,957 Shares 251,270 Est. Cost $8.12 Unrealized -57.8%

ENGNW enGene Holdings Inc. 0.3%

Value ($000) $404 Shares 475,077 Est. Cost $0.85 Unrealized —

— Senti Biosciences, Inc. 0.1%

Value ($000) $129 Shares 195,792 Est. Cost $1.97 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
LXEO	Lexeo Therapeutics	2,157,623	$28,955	23.5%	$12.42	0.0%	Common Stock	52886X107
REPL	Replimune Group	3,001,319	$25,301	20.5%	$17.40	-33.4%	Common Stock	76029N106
NUVB	Nuvation Bio	15,072,340	$22,759	18.4%	$11.18	-88.5%	Common Stock Class A	67080N101
ENGN	enGene Holdings Inc.	1,131,175	$10,441	8.5%	$10.40	0.0%	Common Stock	29286M105
—	Morphic Holding	309,846	$8,948	7.2%	$19.82	—	Common Stock	61775R105
—	Spruce Biosciences	2,161,022	$6,332	5.1%	$24.31	—	Common Stock	85209E109
—	Kronos Bio	3,818,283	$4,773	3.9%	$29.87	—	Common Stock	50107A104
—	Ikena Oncology	2,249,123	$4,431	3.6%	$28.25	—	Common Stock	45175G108
SANA	Sana Biotechnology, Inc.	843,750	$3,443	2.8%	$32.56	-88.7%	Common Stock	799566104
—	Theseus Pharmaceuticals	711,479	$2,881	2.3%	$12.68	—	Common Stock	88369M101
IMUX	Immunic Inc	1,788,160	$2,682	2.2%	$13.89	-91.2%	Common Stock	4525EP101
SYRS	Syros Pharmaceuticals	251,270	$1,957	1.6%	$8.12	-57.8%	Common Stock	87184Q206
ENGNW	enGene Holdings Inc.	475,077	$404	0.3%	$0.85	—	Warrant	29286M113
—	Senti Biosciences, Inc.	195,792	$129	0.1%	$1.97	—	Common Stock	81726A100